Easton Pharmaceuticals Inc. appointed Daniel Bagi to its board.

Bagi will also be president of business development.

He recently helped the company and its Latin American joint venture partner BMV Medica SA de CV secure a sub-licensing deal with with Bayer AG for VS-Sense, a bacterial vaginosis diagnostic product, for Mexico.